ACOBIOM is a biotechnology company specialized in the discovery of genomic or transcriptomic biomarkers and the development of innovative diagnostics. Thanks to its unique scientific expertise in the analysis of gene expression in blood cells and whole blood, ACOBIOM is positioned in the field of Precision Medicine and in the development of diagnostics to help in the choice of the most effective or the most adapted treatment to the biological (phenotypic) profile of patients.

Contact

busdev@acobiom.com

Address

1682 Rue de la Valsière – Cap Delta – Biopole Euromedecine II – 34790 GRABELS – FRANCE

Website

acobiom.com

Targeted indications : Breast cancer, Lung cancer, Gastrointestinal cancers

L’article ACOBIOM est apparu en premier sur OncoSTART.

ADELIS Technologies (ex Picometrics) is an analytical instrumentation company. ADELIS has developed proprietary analysis platform (BIABOOSTER) enabling to concentrate, fractionate and separate free-circulating-DNA directly from plasma samples with unrivalled sensitivity to address cancer treatment and relapse monitoring liquid biopsy applications.

Contact

jcgarcia@adelis-tech.com

Address

310 RUE LOUIS PASTEUR 34790 GRABELS

Contact

www.adelis-tech.com

Targeted indications : Lung cancer, Colorectal cancer, Stomach cancer, Liver cancer, Gastrointestinal cancers, Hematologic cancer

L’article ADELIS est apparu en premier sur OncoSTART.

Advanced BioDesign is a French biotechnology company that is developing a new innovative targeted therapy against resistant cancers, with a first indication in acute myeloid leukemia (AML). Its main anticancer compound, DIMATE (ABD-3001), is a first-in-class suicide inhibitor of aldehyde dehydrogenases 1 & 3 (ALDH1 & 3). By inhibiting this enzyme, ABD-3001 causes cancer cell apoptosis without damaging healthy cells.

Contact

ismail.ceylan@a-biodesign.com

Address

655 ALLEE DES PARCS – BATIMENT D – 69800 SAINT-PRIEST

Website

www.a-biodesign.com

Targeted indications : Cancer du sein, Cancer du poumon, Cancer de la peau, Cancer hématologique

L’article Advanced BioDesign est apparu en premier sur OncoSTART.

The mission of Alderaan Biotechnology is to develop novel therapies to treat cancer by targeting cells from the immune system. Alderaan Biotechnology main program is related to the elimination of Regulatory T cells in the tumour microenvironment via targeting CD25.

Contact

contact@alderaan.fr

Address

04 rue Thénard, 75004 Paris

Website

alderaan-biotechnology.com

Targeted indications : breast cancer, lung cancer, colorectal cancer, prostate cancer, stomach cancer, supportive care, liver cancer, brain cancer, head & neck cancer, gastrointestinal cancer, gynecological cancer, bone cancer, genitourinary cancer, skin cancer, hematologic cancer, lymphoma, myeloma, leukemia, predictive toxicology.

L’article Alderaan Biotechnology est apparu en premier sur OncoSTART.

Contact

contact@amkbiotech.fr

Address

2400 Route des Colles 06410 Biot

Contact

www.amkbiotech.fr

L’article AMKbiotech est apparu en premier sur OncoSTART.

Antineo is specialized in preclinical services to test future anticancer agents. We realize proof-of-concept studies in vitro, ex vitro and in vivo (CDX on immunocompromised, humanized mice, or syngeneic). Our expertise allows to optimize the preclinical steps of drug development strategies with the choice of the indication, relevant model, and adequate references/combinations. We also provide a panel of secondary resistance models (chemo and immunotherapies, immune checkpoint inhibitors).

Contact

contact@antineo.fr

Address

8 avenue Rockefeller 69008 Lyon

Website

www.antineo.fr

Targeted indications : breast cancer, lung cancer, colorectal cancer, prostate cancer, stomach cancer, supportive care, liver cancer, brain cancer, head & neck cancer, gastrointestinal cancer, gynecological cancer, bone cancer, genitourinary cancer, skin cancer, hematologic cancer, lymphoma, myeloma, leukemia, predictive toxicology.

L’article Antineo SAS est apparu en premier sur OncoSTART.

Apmonia Therapeutics is a biotech company committed to develop therapeutic strategies towards multiple types of cancer.

We are developing a first-in-class pipeline of next-generation peptide-based therapies targeting the tumor microenvironment to improve the lives of patients with cancer.

Contact

contact@apmonia-therapeutics.com

Address

CREA, 2 Esplanade Roland Garros, 51100 REIMS

Website

Apmonia Therapeutics

Targeted indications : Colorectal cancer, Brain cancer, Gastrointestinal cancers, Gynecological cancers

L’article Apmonia Therapeutics est apparu en premier sur OncoSTART.

AVATAR MÉDICAL enables surgeons to better prepare their surgical strategy, by converting standard medical images (scanner and MRI) in real time into interactive 3D avatars which can be navigated in virtual reality.

AVATAR MEDICAL is a spin-off of the Institut Pasteur and the Institut Curie, benefiting from four years of advanced research in computer vision and AI.

Contact

contact@avatarmedical.ai

Address

11 Rue de Lourmel, 75015 Paris

Website

https://avatarmedical.ai/

Targeting innovation : Breast cancer, Lung cancer, Colorectal cancer, Prostate cancer, Stomach cancer, Liver cancer, Head and neck cancers, Gastrointestinal cancers, Gynecological cancers, Bone cancer

L’article AVATAR MEDICAL est apparu en premier sur OncoSTART.

Contact

contact@beams.bio

Address

30/32 Boulevard de Sébastopol, 75004 Paris

Contact

www.beams.bio

Targeted indications : Liver cancer, Brain cancer

L’article Beams est apparu en premier sur OncoSTART.

Website: https://biositech.com/

L’article BIOSITECH est apparu en premier sur OncoSTART.